The degree of relief can vary from person to person, depending on factors such as dosage, sensitivity to GLP-1 medications, and how slowly the dose is titrated
(PubMed) Lynch KE, Feldman HI, Berlin JA, Flory J, Rowan CG, Brunelli SM
Glucagon suppression Glucagon is produced by alpha cells in the pancreas
What are we measuring, and when do we stop
It is expanding the GLP1 customer/patient base with 80% of patients new to therapy, driving economics into higher-priced doses, and optimistically starting to repair market confidence that was badly shaken by guidance cuts and competitive pressure from tirzepatide
To date there have been a total of 8 probands reported with GCS deficiency and hemolysis